Immunotherapy and tumor microenvironment
Author:
Funder
National Cancer Institute
Chinese Academy of Sciences
Cancer Research Institute
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference89 articles.
1. Cancer immunotherapy;Couzin-Frankel;Science,2013
2. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;NEJM,2011
3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;NEJM,2012
4. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;NEJM,2012
5. Cancer drug resistance: an evolving paradigm;Holohan;Nat. Rev. Cancer,2013
Cited by 236 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A ratiometric SERS strategy for the prediction of cancer cell proportion and guidance of glioma surgical resection;Biosensors and Bioelectronics;2024-10
2. Herbal Medicines for the Improvement of Immune Function in Patients with Cancer: A Protocol for Systematic Review and Meta-Analysis;The Journal of Internal Korean Medicine;2024-06-30
3. PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy;Cell Death & Differentiation;2024-05-30
4. High-multiplex single-cell imaging analysis reveals tumor immune contexture associated with clinical outcomes after CAR T cell therapy;Molecular Therapy;2024-05
5. New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy;Frontiers in Immunology;2024-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3